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Functional site diversityWe present, to our knowledge, the ﬁrst quantitative analysis of functional site diversity in homologous domain
superfamilies. Different types of functional sites are considered separately. Our results show that most diverse
superfamilies are very plastic in terms of the spatial location of their functional sites. This is especially true for
protein–protein interfaces. In contrast, we conﬁrm that catalytic sites typically occupy only a very small number
of topological locations. Small-ligand binding sites are more diverse than expected, although in a more limited
manner than protein–protein interfaces. In spite of the observed diversity, our results also conﬁrm the previously
reported preferential location of functional sites. We identify a subset of homologous domain superfamilies
where diversity is particularly extreme, and discuss possible reasons for such plasticity, i.e. structural diversity.
Our results do not contradict previous reports of preferential co-location of sites among homologues, but rather
point at the importance of not ignoring other sites, especially in large and diverse superfamilies. Data on sites
exploited by different relatives, within each well annotated domain superfamily, has been made accessible
from the CATH website in order to highlight versatile superfamilies or superfamilies with highly preferential
sites. This information is valuable for system biology and knowledge of any constraints on protein interactions
could help in understanding the dynamic control of networks in which these proteins participate. The novelty
of our work lies in the comprehensive nature of the analysis – we have used a signiﬁcantly larger dataset than
previous studies – and the fact that in many superfamilies we show that different parts of the domain surface
are exploited by different relatives for ligand/protein interactions, particularly in superfamilies which are diverse
in sequence and structure, an observation not previously reported on such a large scale. This article is part of a
Special Issue entitled: The emerging dynamic view of proteins: Protein plasticity in allostery, evolution and
self-assembly.
© 2013 Elsevier B.V. Open access under CC BY license.1. Introduction
Functional sites are sets of residues that are directly involved in the
function of proteins. Those generally include binding sites to other
molecules, and catalytic sites, a subset thereof, which are involved in
the actual catalytic mechanism of enzymes.
Knowing which residues in a protein are important for its function
is important for a number of reasons. For example, it makes it easier
to modify the function of that protein by site-directed mutagenesis.
It can also help identify potential interacting partners for the protein.
Because of their importance, much effort has been put into the
development of computational methods to predict the location of func-
tional sites (see for example [1]). One prevalent approach to predicting
the location of a functional site in a query protein, is to transfer knownrging dynamic view of proteins:
.
Y license.functional site data from homologous proteins. The assumption with
this type of approach is that homologous proteins should have function-
al sites at equivalent locations.
Generally, such homology-based approaches tend to becomemore
reliable as the sequence similarity between proteins increases [2].
However, a number of studies have explored the possibility of trans-
ferring functional site information between remotely related homo-
logues [3–5]. Some studies have even suggested that functional sites
could be transferred with some success between proteins that share
structural similarities but no evidence of homology [6,7].
Proteins are made up of domains, i.e. units of protein evolution that
havewell-deﬁned structures [8]. Several resources have been established
to group such domains by homology into so-called “domain superfam-
ilies” [9,10]. It is generally well accepted that such homologous domains
share some level of functional similarity, and that intermolecular interac-
tions and the functional sites mediating them can often be inherited be-
tween them [6,11].
In-depth analysis of protein domain superfamilies has shown that re-
lated domainsmay often adopt diverse structures, and perform a variety
of functions [12]. This is particularly true for a subset of superfamilies
875B.H. Dessailly et al. / Biochimica et Biophysica Acta 1834 (2013) 874–889that are very diverse, and that are populated by large numbers of do-
mains [13,14,8].
The observation that structural diversity is often more pronounced
in regions directly involved in function [15,16] points at the possibility
that functional sites may vary signiﬁcantly between related protein do-
mains in those large and diverse superfamilies. Over the years, a number
of studies have shown that the underlying assumption that homologous
proteins have their sites in similar locations, may not always hold true.
For example, it was shown that similar domain pairs tend to inter-
act in the same way when sequence identity is 30–40% or higher, but
that more remote similarities (at the fold level for example) are rarely
associated with a similarity in interaction [2].
Previous studies have attempted to look at how diverse the func-
tional sites of different types are between sets of homologous pro-
teins, genes or domains. For example, it was reported that domains
within SCOP families (the family level in SCOP groups together do-
mains that are clearly evolutionarily related, generally with pairwise
sequence identities of 30% or greater), generally have their binding
sites in similar locations [17]. As part of a review on challenges to pre-
dict macromolecular interactions, Wass et al. succinctly reported a
count of ligand-binding sites in SCOP superfamilies and described
that most superfamilies have a small number of such sites, and that
these sites tend to be found in most superfamily members [11].
However, an exhaustive and quantitative analysis of site location di-
versity for all types of functional sites among related protein domains at
the superfamily level remains to be performed. That is the purpose of
this study. We have compared the spatial location of different types of
functional sites between related domains, in an exhaustive manner for
all superfamilies. For that, we ﬁrst select a representative in each super-
family of our dataset, and then map functional sites from each domain
in the superfamily onto the representative. We consider different
types of functional sites separately, and present results for each type.
In an attempt to compensate for the lack of functional site data in
the PDB, we then go on to perform the same analysis but this time
exploiting a simple and intuitive protein functional site predictor, i.e. se-
quence conserved residues.We report that domains in large anddiverse
superfamilies, can have sites in very diverse locations, especially for
protein–protein binding sites, and small ligand binding sites. We ob-
serve that large superfamilies with many domains are the most likely
to have sites in different locations, especially if their domains are also
structurally diverse. This is a novel observation not previously reported
in the literature and has been obtained by performing a more compre-
hensive analysis than earlier studies. It is valuable in drawing attention
to superfamilies where more caution may need to be employed when
inheriting functional site data between relatives.
Our results simply reﬂect what is currently observed in the PDB
when all known site data for a given superfamily is sampled. They
are purely empirical and not intended to provide probabilities for par-
ticular binding sites.
Our functional site mappings are made publicly available for all
superfamilies via the CATH website.
2. Methods
2.1. Deﬁnition of homologous protein domains
In our study, protein domains are considered homologous if they are
part of the same CATH superfamily [9]. Within CATH superfamilies,
domains are further clustered at 60% sequence identity.
Some superfamilies have been shown to be very large and very
diverse [14]. These 60% sequence identity clusters (also called s60
clusters) are useful to quantify diversity in superfamilies. Indeed, 60%
sequence identity has been shown in several studies to be a reasonable
threshold for grouping domains with similar functions [18]. Therefore,
the number of clusters at 60% sequence identity provides an approxi-
mation of the number of diverse functions in the superfamily.We use version 3.5 of the CATH database, which consists of 2626
superfamilies. Since we are focusing on functional site diversity, we ex-
clude all superfamilies consisting of a single 60% cluster, or with no
functional site data. Our ﬁnal dataset consists of 1456 superfamilies.
2.2. Deﬁnition of functional families
Functional families have recently been introduced to the CATH-
Gene3D database [19]. CATH superfamily sequence data are clustered
into functional families, using two related approaches (GeMMA [20]
and Domain Family eXploration program [21]), which consist of rela-
tives likely to have the same function. The GeMMA algorithm identiﬁes
functional families using a hierarchical agglomerative clustering algo-
rithm to produce a tree of clusters built from the leaf nodes to the
root node. This iterative approach ﬁrst clusters close homologues, i.e.
sequences with at least 90% sequence identity, using the program
CD-HIT [22]. For each of these clusters, multiple sequence alignments
(MSAs) are constructed using MAFFT [23]. In the second iteration,
pairs of MSAs are compared using the Comparison of Multiple Protein
Alignments with Assessment of Statistical Signiﬁcance (COMPASS) set
of tools [24]. COMPASS takes two MSAs as input and from these builds
two PSSM proﬁles for comparison purposes. It then calculates the sim-
ilarity of all proﬁle pairs, and the alignments with the highest similarity
are merged. This continues until one cluster remains. The ﬁnal tree of
clusters is partitioned by cutting the tree at a generic threshold. This ap-
proach is referred to as the ‘unsupervised’ method and produces ‘ﬁne’
functional families (FineFams) [20]. The FineFams have been bench-
marked against the Structure Function Linkage Database (SFLD) [25].
Amodiﬁed version of the functional families has since beendeveloped
using a ‘supervised’ protocol [21]. This approach (DFX) detects and ac-
counts for functional ‘chaining’within the tree of clusters. ‘Chaining’ re-
fers to instances of protein domain sequences in a superfamily that
cluster in an unexpected way. In DFX, GO annotation data is used to en-
sure functional coherence in each functional family, and clusters are
only merged if they contain coherent GO terms. However, in some su-
perfamilies the sequence similarity reﬂected in the COMPASS scores
appears to contradict GO term similarity so that domain relatives appar-
ently having different functions are preferentially merged in the hierar-
chy. This phenomenon usually arises because in these superfamilies
domains have a generic functional role that remains unchanged despite
the different functional contexts (reﬂected in different GO terms for
their parent proteins) in which the relatives appear. The DFX method
is described in more detail in Rentzsch et al. [21] and tends to produce
‘coarser’ functional families (FunFams), in which domain relatives in a
cluster are likely to have similar functional roles but the proteins in
which they are found may have different overall functions.
This is illustrated by the fact that relatives in FunFams tend to su-
perpose with higher RMSD than relatives within FineFams (see Sup-
plementary material Fig. A.10), suggesting that since there is a
known correlation between structural and functional diversity [14],
FineFam relatives are closer in function.
As functional families carry out the same general function, each
sequence member is expected to contain the same residues required
for that function. Such sites will therefore be highly conserved
throughout a functional family.
Using these functional families allows us to study these highly con-
served functional residues and observe how such residues compare
between functional families within a superfamily, thereby giving an im-
pression of how functional sites evolve within a superfamily.
2.3. Deﬁnition of functional sites
Catalytic residues are deﬁned as manually curated residues from
the Catalytic Site Atlas (CSA) [26].
Binding sites are deﬁned using theNCBI Inferred Biomolecular Inter-
action Server (IBIS) [27]. IBIS provides information about binding sites
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ganic compounds, peptides and ions. Binding sites for these different
types of ligands were considered separately throughout this work. We
also used quality ﬁlters provided by IBIS when selecting binding site
data. In particular, we ignore any ligands that are not considered biolog-
ically relevant by IBIS. And we also exclude interfaces that are not con-
ﬁrmed by PISA [28]. IBIS functional residues inferred by homology are
not considered here. Finally, in our work, we group together small or-
ganic compounds, peptides and ions in a common category that we
refer to as “small ligands”.
Some proteins have several structures in the PDB [29]. Some struc-
tures may contain ligands and others will not. To ensure maximal
coverage, we always consider all structures of a given protein when
collecting its functional site residues.
2.4. Mapping functional sites between members of the superfamily
Our approach for comparing the three-dimensional location of
functional sites across members of the superfamily consists of three
steps. The mapping protocol is illustrated in Fig. 1.
First, we select a representative for each superfamily. The idea is to
select the superfamily member that is the best structural representa-
tive of the superfamily. In CATH, all 60% sequence identity clusters
have a pre-deﬁned representative. We structurally align all these rep-
resentatives pair-wise against one another using the program SSAP
[30]. The superfamily representative is then selected as the domain
that has the highest cumulative structural similarity SSAP score to
all other sequence clusters in the superfamily. The superfamily repre-
sentative is therefore supposed to be the domain that is most struc-
turally similar to all other domains in the superfamily. This notably
minimizes the risks of misalignments between the representative
and other superfamily members.
The SSAP algorithm has been benchmarked using manually vali-
dated structure comparisons and has been shown to perform well
in identifying equivalent regions between homologous domains
[31]. Even very remote homologues share a conserved structural
core, usually comprising at least 50% of residues, which can be well
aligned between them (see Supplementary material Fig. A.11 for an ex-
ample of the superposition of two very diverse relatives (sequence iden-
tity 6%, RMSD 14 Å), showing the conserved core). Multiple pair-wise
superpositions of homologues within each CATH superfamily, revealing
the structurally conserved core, can be seen on the CATH website.
Once the representative is chosen,we then structurally align it against
all superfamilymembers' domains (i.e. not just the sequence cluster rep-
resentatives). This provides us with a structure-based residue-mapping
between all superfamily members and the representative. As before, we
use SSAP for the structural alignments.
Finally, we map the functional site residues in individual superfam-
ily members onto the superfamily representative. Therefore for each
position in the representative, we know whether it maps to functional
residues in any superfamily members, and what these superfamily
members are. If a functional residue from another domain in the super-
familymaps to a gap in the structural alignmentwith the representative
domain, that residue is ignored in the rest of the analysis. The frequency
at which individual residues on the representative domain have their
equivalent residues in other domains involved in functional interactions
can be counted (see Fig. 1).
We decided not to limit our analysis to surface positions, for several
reasons. First, there is no universally accepted deﬁnition of surface res-
idue. Secondly, it is common for residues that should be considered bur-
ied by most standards, (e.g. relative surface accessibility lower than
0.05) to be involved in function. For example, it was reported that cata-
lytic sites have low relative solvent accessibilities, and up to 5% of them
are fully buried [32]. Also, a position that is buried in one structure may
be surface-accessible in another structure of the same protein due to
conformational changes. Finally, functional residues used in this workare obtained from the CSA and IBIS resources, and were originally
deﬁned as functional based on a careful analysis of the literature, or
using protein-ligand complexes of known structure in the PDB. In both
resources, buried residues may be considered functional, and in order
not to lose any data, we chose not to include extra constraints of surface
accessibility.
In addition to performing a mapping of sites to a superfamily repre-
sentative, we have used the same strategy to map sites for a functional
family (FineFam) to the FineFam representative, in order to examine
site coverage for a more functionally coherent grouping of relatives.
2.5. Conservation analysis
Sequences in functional families are aligned using MAFFT [33] and
conservation scores for each position in the alignments are computed
using Scorecons [34]. A conservation score threshold of 0.7 was em-
pirically chosen to deﬁne conserved residues, based on previous stud-
ies in our group and comparison with known functional residues in a
subset of alignments.
2.6. Computing overlap between conserved and functional residues
Residue enrichment analysis has been used to assess the purity of dif-
ferent types of functional families (i.e. FunFams or FineFams). Functional
families ideally contain sequences that code for a protein with the same
molecular function, and therefore the same functional residues, e.g. cat-
alytic residues, are expected to feature in all of the sequences throughout
the functional family as they will be highly conserved.
We have performed enrichment tests, for both FunFamand FineFam
functional families, to ensure that conserved residues are enriched in
functional residues compared to the background dataset of residues,
i.e. all residues in the proteins. For this, we followed the procedure
explained in a previous study [35]. The idea is to compute the propor-
tion of conserved residues that are also functional, Pc, and the propor-
tion of all residues that are also functional, Pa. The enrichment E, is
equal to the difference of Pc − Pa. Enrichment values are then averaged
over superfamilies, and a Wilcoxon Rank-Sum test [36] is performed
over the set of enrichments to check whether Pc values tend to be sig-
niﬁcantly larger than Pa values. Wilcoxon Rank-Sum tests were per-
formed using the function wilcox.test in R [37].
Enrichment scores were also calculated for FunFam and FineFam
alignments stripped of partial sequence fragments. These fragments are
expected to affect the quality of the alignments by introducing numerous
gaps between fragments and full-length protein domain sequences. Se-
quenceswith a length less than 80% of the corresponding functional fam-
ily average sequence length were removed. The remaining functional
family sequences were aligned using MAFFT and residue conservation
scores were calculated using Scorecons. Enrichment scores were then
calculated as previously described.
2.7. Hub analysis
This section and the following one refer to analyses that we
performed to help the interpretation of our results on functional site
diversity.
Data about hubs (from protein interaction networks) was collect-
ed by integrating interaction data from IntAct [38], Mint [39], BioGrid
[40], DIP [41], HPRD [42], Reactome [43] and Virus-Host-Net [44]. For
all proteins in the human genome (Ensembl [45], release 62), a net-
work of interactions was built by ﬁltering to include only physical in-
teractions. CATH domains were then mapped to their parent proteins
in the network, and the number of physical interactions for each par-
ent protein was mapped back to the domain. Hub superfamilies were
deﬁned as any superfamily in which at least one member is involved
in at least 10 interactions. Other cut-offs were considered and did not
(a) Schematic illustration.
(b) Illustration from NAD(P)-binding Rossmann-like domains superfamily
Fig. 1. Mapping protocol. Fig. 1a illustrates the protocol schematically. All domains in a superfamily (domains 1 to 4) are structurally aligned to a superfamily representative. Do-
mains are represented as a dark grey backbone, and individual residues are represented as beads along the backbone. Ligands are represented as purple, red and magenta ellipsoids
that bind to domains 1, 2 and 4, respectively. Binding residues in these domains are coloured in black. Binding residues from the individual domains are then mapped to the rep-
resentative, and the frequency with which representative residues map to binding residues is recorded. In this example, the residues in orange on the representative map to binding
residues in two domains (domains 1 and 2), whereas the residues in green map to binding residues in only one domain (domain 4). The vectors next to some of the positions of the
representative summarise the list of superfamily domains where equivalent residues are involved in binding. Fig. 1b illustrates the protocol with real protein-protein interface data
from domains in the NAD(P)-binding Rossmann-like superfamily. Three individual domains from the superfamily are represented in complex with their protein partners at the
bottom, and their interface residues are mapped on the representative at the top. The domains of interest are shown in cartoon whereas the partner chains are represented as
thin linear chains. The representative is shown both in cartoon and surface representation. Binding residues in the individual domains are coloured black. Residues on the repre-
sentative are coloured grey, green, orange or red depending on the number of individual domains that have a binding residue at that position (0, 1, 2 or 3).
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families (data not shown).
2.8. Structural diversity analysis
Structural diversity within superfamilies can be described quanti-
tatively by clustering domains within them according to structural
similarity, and then counting the number of structural clusters in
the superfamily at a given cut-off of structural similarity.Structural similarity was quantiﬁed using a normalised RMSD score,
which consists of the RMSD multiplied by the length of the largest do-
main in the pair, and then divided by the number of aligned residue
pairs between the 2 domains (see [46] for more details).
The number of clusters then provides a global measure of structur-
al diversity within superfamilies that can be used to compare differ-
ent superfamilies. The structural clusters are identiﬁed as described
in the CATH database, using a normalised RMSD cutoff of 9.0 Å to de-
ﬁne the clusters. We then deﬁne structurally diverse superfamilies as
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peated this analysis using a cutoff of 5.0 Å rather than 9.0 Å.3. Results
3.1. Functional site coverage
In order to evaluate the diversity of functional site spatial locations
amongst members of the same superfamily, we used a strategy
whereby a superfamily representative is chosen, and sites from all
members of the superfamily are then mapped to it via pairwise struc-
tural alignments.
One simple measure of functional site diversity across a superfam-
ily is the coverage of the representative by functional sites, i.e. the
number of positions on the representative that map to a functional
site of a given type (e.g. protein–protein binding sites), divided by
the total number of positions in the representative. If the representa-
tive domain is not too small, high coverage will generally mean that
functional sites from superfamily members can occur at different spa-
tial locations, that when mapped onto the representative, cover most
of its positions.
Two confounding factors must be taken into account with this mea-
sure of diversity. First, if the representative domain is very small, it is
more likely to have a very high coverage. We avoid that problem by
considering only superfamilies where the representative has at least
100 residues. Of the 1456 superfamilies in our initial dataset, 908 have
a large enough representative.
Secondly, high coverage may in some cases be due to a single su-
perfamily member. Indeed, if a single domain in the superfamily has
most of its residues involved in interactions with partner molecules,
the coverage on the representative may be very high. But in such
cases, high coverage is not indicative of diversity of functional sites
between superfamily members. Although such cases are arguably of
interest, they are not the object of the present analysis, and we have
kept them out for clarity. In practice, any superfamily where one do-
main contributes more than 50% coverage of the representative is ig-
nored from our analysis. However, results obtained when including
these superfamilies can be seen in Supplementary material Fig. A.12.
The number of superfamilies that pass this second ﬁlter depends
on the type of site being considered. Table 1 shows, for each type of
functional site, the number of superfamilies left in the dataset after
all ﬁlters have been applied.
Fig. 2 shows the functional site coverage against a simple measure
of superfamily diversity, namely the number of clusters of domains at
60% sequence identity. Four different types of functional sites, namely
catalytic sites, binding sites for small ligands, nucleic acid-binding
sites, and protein–protein interfaces, were considered separately.
We observe that coverage is rather limited for catalytic sites,
conﬁrming that these tend to co-occur always in the same general loca-
tion within superfamilies. This can be explained in part by their small
size, and from the fact that their location may be rather constrained
by steric considerations, such as the need for a pocket in which the re-
action is performed [32]. Supplementary material Fig. A.13 shows that
the functional site coverage follows a highly similar trendwhen plotted
against the number of domains in a superfamily.Table 1
Number of superfamilies considered in the dataset for each type of func-




Nucleic acid binding sites 116
Small ligand binding sites 659In contrast, we observe large coverage of the representative by pro-
tein–protein binding sites, for a signiﬁcant number of superfamilies.
This indicates that in these superfamilies, protein–protein interfaces
can occur in any topological location. Since we have summed protein–
protein sites from all relatives in the superfamily onto the representa-
tive, this high coverage suggests that one or more relatives may have
multiple partners with different sites and also that binding partners
and their sites may differ between relatives. In particular, we can see
that for the vast majority of superfamilies with signiﬁcant diversity
(e.g. more than 20 60% sequence identity clusters), more than 60% of
residues in the representative map to protein–protein interfaces.
Binding sites for small ligands are more limited in their distribution,
which would be expected from the fact that small ligands are generally
smaller than macromolecules. Yet, we also note the presence of several
superfamilies with large coverage. A handful of superfamilies have cov-
erage values over 80%, and a signiﬁcant fraction of superfamilies have
coverage over 50%. This is somewhat unexpected as small-ligand bind-
ing sites are generally quite small by deﬁnition. However, it cannot be
excluded that in some cases confounding factors may also play a role.
For example, in some relatives in the P-loop superfamily, some artiﬁcial
ligands have been used in a screening study that ﬁnds lots of potential
binding sites.
Nucleic acid-binding site data ismore sparse.Many superfamilies do
not have any such binding sites, and only a few have coverage values
above 30% for these types of sites. A large number of superfamilies
have a representative coverage of 0 for nucleic acid binding, suggesting
no domainswithin them are involved in that type of function. This illus-
trates the fact that nucleic-acid binding is a more unusual ability than
binding other protein chains or small ligands.
Several DNA-binding domains exist within the promoter regions of
transcription factors. These domains include zinc ﬁngers, homeobox
domains, helix-turn-helices and leucine zippers [47,48], which tend to
favour particular sites. These sites are represented as conserved consen-
sus sequence motifs [49].
3.2. Site coverage increases with sequence diversity in the superfamily
Generally, we note that superfamilies with signiﬁcant diversity
tend to display large functional site coverage values.
Supplementary material Fig. A.14 shows the functional site cover-
age ﬁrstly against the number of superfamilies with this coverage and
secondly against the number of domain sequences in superfamilies
with this coverage. Four different types of functional site have been
analysed, as in Fig. 2.
The functional site coverage of catalytic residues in Supplementary
material Fig. A.14a is limited, as previously shown in Fig. 2a. Across Sup-
plementary material Fig. A.14, a trend can be observed where the super-
familieswith very high functional site coverage are also the superfamilies
with the highest number of domain sequences. In the small ligand bind-
ing sites (Supplementary material Fig. A.14b) for example, at 97% func-
tional site coverage, there is a single superfamily, which has a total of
727,424 sequences, the largest number of domain sequences observed
in this ﬁgure. At 99% functional site coverage in the protein–protein
interface sites (Supplementarymaterial Fig. A.14d), there are four super-
families with a total of 129,941 domain sequences, which is a signiﬁcant
proportion of all the domain sequences. This suggests, as expected, that
superfamilies with large numbers of sequences are more likely to have
higher diversity of functional site location.
In the rest of the manuscript, we will mostly illustrate diversity by
referring to the situation with protein–protein interfaces, and small
ligand binding sites to a lesser extent.
3.3. Illustrations of functional site coverage
In order to help further understand Fig. 2, we illustrate them with
examples taken from different regions of the coverage plots (see Fig.
(a) Catalytic Sites (b) Small Ligand Binding Sites
(c) Nucleic Acid Binding Sites (d) Protein-Protein Binding Sites
Fig. 2. Functional site coverage and sequence diversity of domain superfamilies. Each plot shows the data for a speciﬁc type of functional site. Each superfamily is represented as a
dot in these plots. Functional site coverage on the Y-axis is measured as the proportion of residues in the representative that map to at least one site in any member of the super-
family. Superfamily diversity on the X-axis is measured as the number of clusters of sequences at 60% sequence identity in the superfamily.
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protein interfaces.
3.3.1. Superfamilies with low site coverage and low sequence diversity
Fig. 3 illustrates the situation for the bacterial GAP domain super-
family, which is characterised by low diversity and low protein–
protein interface coverage. This is a typical example of a superfamily
that is not highly populated and not sequence diverse, and for which
the interfaces in the different characterised members are found in sim-
ilar locations.
The GTPase activating protein (GAP) is a type of bacterial effector
injected into a eukaryotic host cell via the type III secretion system.
Litvak and Selinger [50] examined a multiple sequence alignment of
10 bacterial GAPs and found two short highly conserved motifs across
the different species, together with four completely conserved leucine
residues. The two short motifs were found to provide an extensivenetwork of interactions and structural constraints that are used to
keep a catalytic arginine residue in its highly constrained and optimal
position. These interactions include contacts with the p-loop of the
GTPase, the GTPase switch regions, and with the bound nucleotide
[50]. Fig. 3c shows a heat-map of the representative from the GAP do-
main superfamily with residue positions coloured according to the pro-
portion of domains in the superfamily having a residue at that site
involved in protein interactions. Both motifs are highlighted in red in
Fig. 3c, showing that the residues within these motifs are involved in
protein–protein interactions, and that their location is highly conserved
throughout the superfamily.
Due to the high structural constraints imposed by the catalytic res-
idues in this superfamily, and the nature of the interaction with the
p-loop of the GTPases, it is not surprising to observe that the locations
of protein–protein interactions across the superfamily members are
highly similar in our analysis.
(a) Pseudomonas aeruginosa Exos toxin in
complex with human Rac.
(b) Salmonella Tyrosine Phosphatase SPTP in complex with hu-
man Rac.
(c) GAP domain superfamily representative with
mapped interface residues from other superfamily mem-
bers.
Fig. 3. Example of a small superfamily with limited coverage of protein-protein interfaces. This is the Bacterial GTP-ase Activating Protein (GAP) domain superfamily (CATH code
1.20.120.260). The GAP domain is always displayed in grey cartoon. In Fig. 3a and 3b, the interacting partner is coloured red and blue, respectively. Interface residues on the GAP domain
are coloured black. Fig. 3a and 3b display PDB entries 1he1 and 1g4u, respectively. In Fig. 3c, the representative is displayed in grey cartoons. Residues that map to interface residues in
superfamily members are coloured according to the percentage of members that have an interface residue at that position, using the following colour scale: 0 in grey, 1–20% in blue,
20–40% in green, 40–60% in yellow, 60–80% in orange and 80–100% in red).
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Fig. 4 illustrates the protein–protein interface coverage for the
“Two Dinucleotide Binding Domains” Flavoproteins (tDBDF) super-
family. This is a very large and diverse superfamily with 127 60%
sequence identity clusters, but it has a limited coverage of protein–
protein interfaces (37% of representative residues). This superfamily
is exceptional in that most other large, diverse superfamilies have a
protein–protein interface coverage of at least 50%. The bottom-right
region of the plot is not occupied by many superfamilies (see
Fig. 2d), suggesting as mentioned above, that with a few exceptions,
diverse superfamilies have protein–protein interfaces covering most
spatial locations in the domain structure.
Ojha et al. [51] performed a structural and functional analysis on
1664 members belonging to the tDBDF superfamily. As observed in
our analysis, this enzymatic superfamily is very large and functionally
diverse; members have previously been shown to catalyse many
types of oxidation/reduction reactions in events such as energy metab-
olism, apoptosis, maintenance of redox homeostasis and cellular signal-
ling. A wide variety of substrates are used to carry out these functions,which are either small molecules or proteins. All superfamily members
have two dinucleotide binding Rossmann fold domains on a single
chain, which both belong to the same CATH superfamily (CATH code
3.50.50.60). In order to function correctly, both domains are required;
typically the N-terminal domain binds a ﬂavin adenine dinucleotide
(FAD) and the C-terminal domain binds a pyridine nucleotide. Despite
a high level of functional diversity across the superfamily, (largely due
to the variety of substrates), the position of these cofactors in the active
site remains conserved so as to allow for optimal stereospeciﬁc hydride
transfer between the two cofactors. The pyridine nucleotide is structur-
ally restricted so that it has to interact with the FAD from the re-side,
whose location is conserved across the superfamily. Due to the structur-
al constraints placed upon the two cofactors, the geometry of the bind-
ing pockets is very highly conserved across the superfamily; the stacked
conﬁguration of the cofactors restricts the nicotinamide ring of the pyr-
idine nucleotide from interacting with the isoalloxazine ring from the
re-side of FAD [51]. This results in a single point of access to the FAD
electron site, which in turn limits the number of residues that can be in-
volved in interactionswith acceptor proteins [51]. These constraints are
(a) tDBDF domain from the subunit
A of Adenylylsulfate reductase from Ar-
chaeoglobus fulgidus in complex with sub-
unit B.
(b) tDBDF domain from the flavoprotein subunit of E coli
Quinol-fumarate reductase, in complex with other subunits.
(c) tDBDF superfamily representative with mapped in-
terface residues from other superfamily members.
Fig. 4. Example of a large and diverse superfamily with limited coverage of protein-protein interfaces. This is the “Two-Dinucleotide Binding Domains” Flavoprotein (tDBDF) su-
perfamily (CATH code 3.50.50.60). The tDBDF domain is always displayed in grey cartoon. In Fig. 4a (PDB entry 1jnr) and 4b (PDB entry 1kf6), the interacting partners are repre-
sented as coloured traces. Interface residues on the tDBDF domain are coloured black. The interface occurs in a similar location in these two distinct domains. Fig. 4c shows the
representative with residues coloured according to the fraction of superfamily members that have an interface residue at that position, following the same colour scheme as de-
scribed at Fig. 3.
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served to be involved in protein–protein interactions.
3.3.3. Superfamily with high site coverage and high sequence diversity
Fig. 5 illustrates the protein–protein interface coverage for the
NAD(P)-binding Rossmann superfamily. This superfamily is extremely
large with 402 60% sequence identity clusters. The NAD(P)-binding
Rossmann domains bind the coenzyme nicotinamide adenine dinucleo-
tide (NAD+) and a large selection of catalytic domains, which have
been shown to come from at least seven different SCOP superfamilies
[52]. NAD+ is a co-factor in redox reactions in which the nicotinamide
ring accepts a hydrogen in a reversible reaction. The type of catalytic do-
main that is bound to the Rossmann domain determines the substrate
speciﬁcity and the exact catalytic reaction of the enzyme. Bashton and
Chothia [52] discovered four different types of connections between cat-
alytic and Rossmann domains depending on whether the catalytic do-
main occurred at the N- or C-terminus, in the middle of the Rossmann
domain (Fig. 5c and e) or whether it includes the Rossmann domainwithin it (Fig. 5a). For the majority of the examples illustrated in the
Bashton and Chothia paper [52], the catalytic domain lies close to the
yellow region highlighted in Fig. 5f.
Fig. 5 shows a summary of the mapping of protein–protein inter-
faces on the superfamily representative. As this ﬁgure illustrates,
protein–protein interfaces occur across a broad range of topological
sites in this superfamily. Fig. 5a, for example represents the human
S-adenosylhomocysteine (AdoHcy) hydrolase homodimer [53]. It
consists of two chains, each comprising a NAD(P)-binding Rossmann
domain nested within a catalytic domain. The method with which
this enzyme binds to its cofactor, NAD, is thought to be unique and
is important to its catalytic mechanism. Turner et al. [53] found that
the dimer has a unique NAD-binding domain interface between heli-
ces α17 of the catalytic domain on one monomer and αC of the
NAD(P)-binding Rossmann domain on the second monomer (black
helix in Fig. 5a), and between α18 of the catalytic domain on one
monomer and residues at the adenine side of the NAD binding site
in the second monomer. In Fig. 5d the protein–protein interactions
(a) Human S-adenosylhomocysteine hydro-
lase homodimer.
(b) Rat brain 3-hydroxyacyl-CoA dehydro-
genase homodimer.
(c) Human NEDD8-activating enzyme E1
regulatory subunit in complex with the cat-
alytic subunit.
(d) Sulfur carrier protein ThiF adenylyl-
transferase in a heterotetrameric complex
with Sulfur carrier protein ThiS, from Es-
cherichia coli.
(e) Homotetramer of GDP-D-mannose dehy-
dratase from Aquifex VF5.
(f) Rossmann superfamily representative
with mapped interface residues from other
superfamily members.
Fig. 5. Example of a large and diverse superfamily with large coverage of protein-protein interfaces. This is the NAD(P)-binding Rossmann superfamily (CATH code.40.50.720). The
Rossmann domain is always displayed in grey cartoon and shown in the same orientation. Extra-domains from the same chain are displayed as grey traces. Interacting partners are
displayed as coloured traces. Interface residues on the Rossmann domain are coloured black. Fig. 5a through to 5e display PDB entries 1a7a, 1e3w, 1tt5, 1zud, and 2z1m, respec-
tively. Fig. 5f shows the representative with residues coloured according to the same colour scheme as described at Fig. 3.
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wards the N-terminal part of ThiF to form a mostly hydrophobic in-
terface with a second ThiF in the complex.
In spite of the fact that protein–protein interfaces occur at all topolog-
ical sites in this superfamily, Fig. 5f shows that some regions (shown in
yellow and orange) are clearly preferred over others (shown in blue).
This phenomenon of preferential colocation shall be discussed further
in the next section.3.4. Functional site preferential colocation
The fact that coverage is high for a particular type of functional site
(e.g. protein–protein interfaces), in a given superfamily, does not nec-
essarily mean that all the locations are used equally often by different
relatives, for function.
For example, as shown in Fig. 5, in relatives in the Rossmanndomain
superfamily discussed in Section 3.3.3 above, some protein partners
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more remote sites. Furthermore, different relatives are binding diverse
partners at different remote sites.
Throughout our analysis, numbers of non-redundant domains that
have a site mapping at any position on the representative are recorded,
so that we can see if some positions are preferred over others.
Studying the tendency of functional sites to colocate in similar to-
pological locations within superfamilies was not a direct aim of this
analysis. Indeed, previous studies have reported the existence of pre-
ferred sites among remote homologues and even between structural-
ly similar although not necessarily related proteins [6,7]. However,
we used our dataset to perform a very simple analysis of preferential
colocation.(a) Catalytic Sites
(c) Protein-Protein Interfaces
Fig. 6. Preferential location of functional sites in CATH superfamilies. Each dot represents a
identity clusters that have a functional site at a given position (or, in other words, it shows
proportion is the highest). The X-axis shows the number of 60% seq. id. clusters that have fun
seq. id. clusters are considered here. This is to avoid meaningless fractions on the Y-axis (5The approach we followed was to verify whether there was, in each
superfamily, at least one position where a majority of subfamilies (S60
clusters) have a functional site. As shown in Fig. 6 we observe that
this seems to be the case formost superfamilies, thus conﬁrming the ex-
istence of preferred locations.
The plots indicate that themajority of superfamilies have at least one
position that is used as a functional site in at least 50% of the subfamilies
(S60 clusters) in the superfamily. The constraints to produce these plots
are rather strict aswe considered only superfamilieswith at least 10 60%
sequence identity clusters with functional site data. This explains why
the data is so sparse for nucleic-acid binding sites and catalytic sites.
We chose these severe constraints to ensure that any preferential
colocation of sites thatwas detectedwas not caused by under-sampling.(b) Small Ligand Binding Sites
(d) Nucleic Acid Binding Sites
superfamily. The plots show, on the Y-axis, the maximum proportion of 60% sequence
the proportion of 60% seq. id. clusters with a functional site at the position where that
ctional site data of that type in the superfamily. Only superfamilies with at least 10 60%
0% of 2 clusters is only one cluster).
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data does not permit to draw any strong conclusion.
Whilst Fig. 6, suggesting preferential location, may appear to con-
tradict the observation of high site coverage shown in Fig. 2, essen-
tially there is no contradiction in the plots. A common binding site
and high site coverage are both possible in a superfamily. This notably
arises from the fact that a relative can bind multiple partners. So a
common site may be used by many relatives but each of those rela-
tives may bind additional partners at different sites.
As well as examining site preference in superfamilies, we also inves-
tigatedwhether the site coverage tends to be lower for a functional sub-
family than for superfamilies i.e. lower site coverage for relatives sharing
similar functional properties and therefore more likely to have similar
protein partners. Supplementary material Fig. A.15 shows that most
functional subfamilies examined have site coverage lower than 30% for
protein interactions. The trends observed are generally much lower
than observed for superfamilies (see Fig. 6 and Supplementary material
Fig. A.16) supporting the idea that the higher site coverage observed
when the whole superfamily is considered is largely due to the fact
that functionally different relatives are exploiting different sites on the
domain for binding ligand/protein partners.
In Fig. 7, we illustrate protein–protein interface coverage summaries
for the most diverse superfamilies, to show what the different patterns
of preferential colocation are. As can be seen, all of these superfamilies
usemost of their locations for protein–protein interfaces, but one region
is generally preferred over others.
3.5. Functional site coverage compared with measures of function and
structure diversity
Next, we attempt to interpret our results by using a number of
measures of functional diversity and structural diversity of superfam-
ilies and contrasting that with the coverage in functional sites.
For this, we check the distribution of superfamilies with different
structural and functional features, and see if any signal is observed
that may help identify superfamilies that have greater functional
site location versatility.
3.5.1. Site coverage of enzyme and non-enzyme superfamilies
First we tested whether enzymatic superfamilies differed from
non-enzymatic superfamilies in terms of functional site coverage. The
idea is that enzymes are generally thought to harbour onemain canon-
ical active site, therefore being perhaps less likely to havehigh coverage.
However, there does not seem to be an obvious trend in the distribution
of enzyme superfamilies in terms of functional site coverage of any type.
The lack of any obvious difference in coverage between enzyme and
non-enzyme superfamilies may reﬂect the fact that whilst enzymes
have a preferred active site for binding substrates, they also use other
regions on the protein surface for binding protein partners e.g. in
enzyme complexes. The plots are shown in Supplementary material
Fig. A.17.
3.5.2. Correlation of site coverage with tendency to be a hub protein
We then checked whether superfamilies that contain domains from
protein interaction network hub proteins display different patterns of
functional site plasticity. At least some categories of hubs are thought
to interact with their many partners via several distinct sites on their
surfaces. The distribution of hub-related superfamilies is shown in Sup-
plementarymaterial Fig. A.18. As can be seen from the plots, the hub su-
perfamilies do not cluster in a particular area of the plot. Some hub
superfamilies have low interface coverage, whereas others have very
high coverage. This can be explained by a number of factors. First
hub-related superfamiliesmay not always bedirectly involved in the in-
teractions, because hubs are deﬁned at the protein level, not the domain
level. Second, structural data is missing for a large number of interac-
tions so that although interactions are known, interfaces may not be.Finally, and as alluded to above, from a biological standpoint, hubs
may be using the same interface for many of their interactions.
However, clearly information collected by our analysesmay be help-
ful for other researchers investigating putative hub domains. For exam-
ple, domains thought to be acting as hubs which belong to diverse
superfamilies, with low site coverage, may exploit a single speciﬁc
surface in their interactions which would allow them to regulate these
interactions.
3.5.3. Structural diversity
When displaying the structural diversity of superfamilies on the
plots shown in Fig. 2, we observe that structurally diverse superfamilies
mostly have high site coverage (see Fig. 8). This is the case whether we
measure structural diversity by the number of clusters generated using
a 9.0 Å RMSD threshold or 5.0 Å RMSD threshold (see Supplementary
material Fig. A.19 and A.20). Indeed, a Wilcoxon Rank-Sum test per-
formed to compare the distributions of coverage values for structurally
diverse superfamilies vs the other ones, shows that structurally diverse
superfamilies have signiﬁcantly higher coverage values, for all types of
sites except nucleic acid binding sites (see Table 2).
Previouswork has shown that oneof theways bywhich homologous
domains were able to explore new regions of functional space, was by
exploiting structural embellishments, for function. It was shown that
these structural embellishments have a tendency to be directly involved
in binding or catalysis [16,15]. It should however be noted that super-
families with high site coverage are not necessarily the most diverse
ones, suggesting that high site coverage is not exclusively a function of
structural diversity.
Results here point at the existence of large and diverse superfamilies
that may exploit different mechanisms for novel function exploration.
Results also seem to show, at least for protein–protein interactions,
that the very diverse superfamilies are very versatile in adapting differ-
ent parts of their surface for interactions.
3.6. Conserved sites coverage
One problemwith the known functional site data is that it is notori-
ously incomplete. Known functional sites are for the most part char-
acterised by solving structures of proteins in complex with their
partners. However, proteins of known structures only represent a very
small fraction of known proteins. Furthermore, even for proteins for
which a structure is available, many binding sitesmay still be unknown.
In order to account for that problem, we have performed a similar
analysis as described above, but this time using a set of predicted
functional residues, i.e. residues that are conserved in functional fam-
ilies of protein domains. We map these conserved residues onto su-
perfamily representatives in the same way as for known functional
residues.
For this part, we ﬁrst needed to conﬁrm that the conserved residues
identiﬁed in our functional families of protein domains are indeed ap-
propriate proxies for functional residues. To do this, we evaluated the
extent to which such conserved residues overlapped with the known
functional sites whenever these were available. For all functional fami-
lies where known functional residues were available, we calculated the
proportion of such residues being recovered by our conserved residues.
For catalytic residues, we found that about 58% and 60% were
conserved in FunFam and FineFam alignments, respectively. Following
the removal of sequence fragments from these alignments, this value
rose to about 76% and 78% for FunFams and FineFams, respectively.
Comparing the two types of functional family, more conserved catalytic
residues are observed in the FineFams (Fig. 9).
For binding residues, we found that protein–protein interface resi-
dues are the least often conserved across functional family types,
whereas the small ligand binding residues are themost often conserved
(Table 3). We also found that the number of conserved functional resi-
dues increased in both family types following the removal of fragments.
(a) OB-fold Nucleic acid-binding
proteins (CATH code 2.40.50.140)
(b) Periplasmic binding protein-like
II (CATH code 3.40.190.10)
(c) Protein Kinase-like (PK-like)
(CATH code 3.30.200.20)
(d) Thioredoxin-like (CATH code
3.40.30.10)
(e) Trypsin-like serine proteases
(CATH code 2.40.10.10)
(f) Aldolases (CATH code
3.20.20.70)
(g) Winged Helix DNA Binding do-
mains (CATH code 1.10.10.10)
(h) Immunoglobulins (CATH code
2.60.40.10)
(i) P-loop containing NTP Hydro-
lases (CATH code 3.40.50.300)
(j) NAD(P)-binding Rossmann-like
domains (CATH code 3.40.50.720)
Fig. 7. Protein-protein interface coverage for 10 most populated superfamilies in the CATH database. The colour scheme is the same as in Fig. 3.
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est levels of functional residue conservation, showing that conserved
residues in this type of functional family are better proxies for function-
al residues.
We also performed enrichment tests as described in the Methods
section, to ensure that conserved residues are enriched in functional
residues when compared to the background set of residues. Wilcoxon
Rank-Sum tests performed over the enrichment values provided highlysigniﬁcant P-values for all functional site types except IBIS protein–
protein interface residues, suggesting that conserved residues are
highly enriched in the remaining three types of functional residues
when compared to all residues: catalytic residues, nucleic acid binding
residues, and small ligand binding residues (see Table 4).
When we use these conserved residues to perform our analysis of
site coverage within superfamilies (as presented in Fig. 2 for known
sites), we observe a distribution of coverage values that conﬁrms the
(a) Protein-protein interface coverage. (b) Small ligand binding site coverage.
Fig. 8. Functional site coverage versus superfamily diversity, with structurally diverse superfamilies coloured in red. Superfamilies are deﬁned as structurally diverse if they contain
at least 2 structural clusters (see Methods section).
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ilies (see Supplementary material Fig. A.21, and Table 5).
4. Discussion
Our results show that although there is sometimes a preference for
at least one residue site in a superfamily, other sites can be exploited
usually by protein partners and particularly in diverse superfamilies a
large proportion of the surface has been sampled in this way, by differ-
ent relatives.
If we partition the superfamily into more functionally coherent sub-
families, we see that there is a greater tendency to exploit a common
site (see Supplementary material Fig. A.15 and A.16). Therefore, the in-
crease in coverage obtained when accumulating site data from all rela-
tives across a superfamily, is due to the fact that some of the functional
subfamilies must exploit different sites on the domain surface.
These observations (i.e. preferred sites and multiple sites across the
domain) are not contradictory. A common binding site and high surface
coverage are both possible in a superfamily. This notably arises from the
fact that a relative can bindmultiple partners. So a common site may be
used by many relatives but each of those relatives may bind additional
partners at different sites.
For example, in an enzyme superfamily, a domainmay bindmultiple
protein partners in an enzyme complex or oligomeric unit. One of these
partners may bind at the common superfamily active site as it may con-
tribute additional catalytic residues to the site. Another may bind at a
different site, quite remote from the common active site. Summed
over the whole superfamily this can result in one or more common
sites used by many relatives but also many additional unique sitesTable 2
Results from aWilcoxonRank-Sum test comparing functional site coverage values
for structurally diverse superfamilies versus structurally similar superfamilies.
Site type P-value
Catalytic sites 4.894147 × 10−19
Protein–protein interfaces 9.74794 × 10−18
Nucleic acid binding sites 0.04609505
Small ligand binding sites 6.176701 10−16over the surface corresponding to the binding sites of different ligands/
partners bound by different relatives.
Therefore, for the protein–protein interaction plots, the large cov-
erage i.e. diversity of sites being exploited by different relatives, could
be associated with changes in the speciﬁcity of the proteins that they
bind. Previous analyses on protein families in yeast and Escherichia
coli, have shown by analysing GO terms, that different paralogous rel-
atives within a superfamily tend to bind to different protein partners
[54]. Our results here may suggest that these diverse protein partners
bind at different sites on the domain surface. Similarly, when consid-
ering an individual relative with multiple protein partners, it may be
beneﬁcial to have these partners binding at different sites, to reduce
cross effects, unless binding to a common site was somehow impor-
tant for regulation.
We believe that our observations relate to both physical consider-
ations and evolutionary ones. For example, in enzymes, one of the
deepest surface pockets are frequently exploited for binding sub-
strates [55] and this is often used by all the relatives. This site is there-
fore highly conserved throughout evolution, presumably because it
has the best features to support a chemical reaction.
However, for metal binding or protein interactions where the ac-
tivity does not need to be so exquisitely tailored to provide the pre-
cise stereochemistry of catalytic residues, most parts of the surface
may be able to evolve the right characteristics for binding ligands/
protein partners. Therefore different functional surfaces can emerge
during evolution in duplicated domains.
Relatives in different organisms often bind different metal ions and
can sometimes exploit different co-factors. The fact that it appears
possible for domains to change their surfaces during evolution to bind
differentmolecules clearly contributes to the diversity in functional rep-
ertoires that we see between different species.
Our analyses have been purely empirical and reﬂect what is cur-
rently observed in the PDB when all relatives with known site data
are sampled. They are not intended to infer probabilities of binding to
particular sites.
There are a number of issues to keep in mind when interpreting our
results. First, the diversity of site locationswepresent in thiswork is like-
ly to be a lower bound. There are relatively few known functional sites in
biological databases. For example, if you consider all the known site data
available for the functional subfamilies in our analysis, Supplementary
Fig. 9. Comparison of the number of catalytic residues that are conserved in each type of functional family, before and after removing fragments.
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less of the subfamilies have annotations. The reason for this lack of site
data is that themain experimentalmethod for identifying functional res-
idues is still X-ray crystallography with a bound ligand. These data can
be difﬁcult to obtain, and therefore, for many proteins, functional resi-
dues are yet unknown.Table 3
The proportion of IBIS functional residues that are also conserved.







FunFams (+ fragments) 26.15% 21.50% 31.63%
FunFams (− fragments) 37.32% 33.76% 47.41%
FineFams (+ fragments) 34.70% 24.34% 35.02%
FineFams (− fragments) 47.73% 39.28% 52.03%
Table 4
This table shows the P-values calculated from enrichment scores using Wilcoxon Rank-Sum
are consistently highly signiﬁcant, suggesting that the conserved residues in both family ty
Family type Catalytic residues IBIS nucleic acid bind
FunFams (+ fragments) b2.2 × 10−16 5.874 × 10−06
FunFams (− fragments) b2.2 × 10−16 3.555 × 10−07
FineFams (+ fragments) b2.2 × 10−16 7.047 × 10−09
FineFams (− fragments) b2.2 × 10−16 2.187 × 10−06For example, there could be transient complexes formed between
a domain relative and protein partners. Our current observation on
the proportions of relatives exploiting a common site will generally
not take account of these protein partners because of the difﬁculty
of capturing transient interactions. If these transient partners all ex-
ploit the same site, the tendency to use a preferred site within a su-
perfamily becomes higher.
Secondly, our analysis relies on structural alignment between do-
mains for functional residue mapping. We believe that by using the ap-
proach described here, we have minimized the risks of mis-alignments
between residues of the representative and those of other domains in
the superfamily. Indeed, we rely on structural alignments which are
generally safer than sequence alignments, we use pairwise alignments
rather than the more difﬁcult multiple structure alignments, and we
focus on comparisons between individual domains within superfam-
ilies. This should generally ensure alignments that are as reliable-
as-it-gets. However, we cannot rule out odd mis-mappings betweentests. Catalytic, IBIS nucleic acid binding, and IBIS small ligand binding residue P-values
pes are highly enriched in these three types of functional residues.
ing IBIS protein–protein interface IBIS small ligand binding
0.5516 b2.2 × 10−16
0.3546 b2.2 × 10−16
0.009475 b2.2 × 10−16
0.0006779 b2.2 × 10−16
Table 5
Proportion of superfamilies where the site coverage on the representative is higher
than 50%. The numbers between brackets are the actual fractions.
Site type Proportion of high
coverage superfamilies
Catalytic sites 0% (0/328)
Protein–protein interfaces 20.5% (132/645)
Nucleic acid binding sites 7.8% (9/116)
Small ligand binding sites 8.0% (53/659)
Conserved sites (FineFams) 38.8% (541/1393)
Conserved sites (FunFams) 22.4% (299/1333)
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however, we expect such mis-mappings to occur between relatively
small windows around the residues of interest.
Third, IBIS uses a distance cut-off of 4 Å from the ligand to deﬁne
binding residues. This cut-off may sometimes slightly over-estimate
the amount of residues to include in functional sites. However, similar
and sometimes larger distance cut-offs are routinely used for deﬁning
functional sites. We trust that in the majority of cases, this is a reason-
able threshold to be used.
Fourth, structural diversity within superfamilies means that some
members may sometimes include large insertions or embellishments
that are not present in other members. In particular, the representative
may, more often than not, not include some of the embellishments that
are present in other members of the superfamily. In those cases, we are
potentially missing all the functional sites that occur on these embel-
lishments, when we map functional residues on the representative.
Again, this results in under-estimating functional site diversity across
the superfamily. Given thewaywe chose the representative, we should
minimize the risk of having the opposite situation, i.e. cases where the
representative contains embellishments that are not present in other
members of the superfamily. Indeed, the presence of such embellish-
ments reduce overall structural similarity to other superfamily mem-
bers, thus reducing the chance of a domain with large embellishments
being selected as representative. As a reminder, the representative is
chosen as the domain with the largest cumulative structural similarity
to all other members of the superfamily. In addition, even if a represen-
tative with large and unique embellishments is selected, this means
that once again we underestimate the real diversity of functional sites,
since that would mean that those embellishments cannot map to func-
tional sites in other domains, and therefore, the representative coverage
in functional sites diminishes.5. Conclusion
In this work, we have performed a comprehensive analysis of all
superfamilies for which there is sufﬁcient data, to check whether func-
tional sites are constrained to a few locations or can appear anywhere
on the domain.
We provide quantitative analyses that document superfamilies in
which related domains differ in terms of the location of their func-
tional sites. We show that this phenomenon is pervasive and actually
occurs in a signiﬁcant number of superfamilies, especially those that
contain the largest numbers of domains. In particular, we demon-
strate that if a superfamily reaches a certain level of functional diver-
sity, functional site location diversity also ensues.
This diversity in functional sites has consequences in the waywe un-
derstand proteins, in particular their functional plasticity. It also has con-
sequences on the approaches used for predicting functional sites. Since it
appears that functional sites can sometimes occur in many different lo-
cations among related domains, relying too strictly on homology transfer
for functional site predictionmay sometimes result inmissing potential-
ly interesting predictions. In that context, prediction methods that rely
not only on transfer by homology but also use a range of other featuressuch as structural and physico-chemical properties of residues, may
also be helpful.
Our data can also be useful in highlighting which superfamilies are
particularly versatile in terms of their functional site location. All our
data on functional site diversity within superfamilies are available
from the CATH website.
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